Hayes, AR ; Mak, IYF ; Evans, N...
https://discovery.ucl.ac.uk/id/eprint/10112272/1/511662.pdf.  , 2021

Manoharan, P ; Lamarca, A ; Navalkissoor, S...
https://discovery.ucl.ac.uk/id/eprint/10124448/1/Safety,%20tolerability%20and%20clinical%20implementation%20of%20ready-to-use%20sup68supgallium-DOTA0-Tyr3-octreotide%20%28sup68supGa-DOTATOC%29%20.pdf.  , 2020

Laskaratos, F-M ; Armeni, E ; Shah, H...
https://discovery.ucl.ac.uk/id/eprint/10086621/1/Predictors%20of%20antiproliferative%20effect%20of%20lanreotide%20autogel%20in.pdf.  , 2020

Manoharan, Prakash ; Lamarca, Angela ; Navalkissoor, S...
Manoharan , P , Lamarca , A , Navalkissoor , S , Calero , J , Chan , P S , Julyan , P J , Sierra , M L , Caplin , M & Valle , J 2020 , ' Safety, tolerability and clinical implementation of 'ready-to-use ' (68)gallium-DOTA0-Tyr3-octreotide (Ga-68-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) ' , ESMO Open , vol. 5 , no. 2 , e000650 . https://doi.org/10.1136/esmoopen-2019-000650.  , 2020

Mallorie, A ; Chan, K ; Ioannidis, S...
doi:10.1097/MNM.0000000000000866.  , 2018

Chan, K ; Luong, T ; Navalkissoor, S
doi:10.1097/rlu.0000000000001898.  , 2018

Navalkissoor, S ; Flux, G ; Bomanji, J
https://discovery.ucl.ac.uk/id/eprint/10029096/1/Bomanji_462.full.pdf.  , 2017

Nastos, K ; Cheung, VT ; Toumpanakis, C...
https://discovery.ucl.ac.uk/id/eprint/1540764/1/Khoo_Final%20submission.pdf.  , 2017

Navalkissoor, S ; Bailey, P.S.J ; Quigley, A.M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2012

Liu M. (4150441) ; Armeni E. (10019489) ; Navalkissoor S. (10019492)...
https://figshare.com/articles/dataset/Supplementary_Material_for_Cardiac_Metastases_in_Patients_with_Neuroendocrine_Tumours_Clinical_Features_Therapy_Outcomes_and_Prognostic_Implications/13625114.  , 2021